Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT06624579 Sponsor: FEDERICA FURFARO Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT06624579
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with ulcerative colitis (UC) for at least 12 weeks before joining the study.
  • People who are 18 years of age or older.
  • People of any gender or sex.
  • People whose ulcerative colitis is currently active enough to warrant starting a type of medication called "small molecules," based on specific scores measured during a bowel examination and symptom assessment (confirm with trial site).
  • People who have no medical reasons preventing them from undergoing a bowel camera examination (endoscopy) or a related imaging procedure.
  • People who are able to understand the study procedures, follow them as required, and sign a consent form agreeing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose bowel examination results show a disease activity score below a certain level at the start of the study (confirm with trial site).
  • People who are pregnant.
  • People who have any medical reason that prevents them from safely undergoing any of the study procedures, including those with an allergy to a substance called fluorescein (used during one of the imaging procedures).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0039+0226432069

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
FEDERICA FURFARO
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 October 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov